Recent developments in targeted therapies

Bookmark and Share
Published: 6 Jun 2016
Views: 1128
Dr Stephen Nimer - University of Miami, Miami, USA

Dr Nimer speaks with ecancertv at ASCO 2016 about tumour heterogeneity.

Personalised and targeted therapies have offered new insights into oncogenic pathways and limiting cell growth growth, and Dr Nimer discusses the use of neoantigens and immunotherapy to modulate the tumour microenvironment.